About
Kazuhiro Ito, PhD, DVM, is a Principal Research Fellow in Respiratory Molecular Pharmacology at the National Heart & Lung Institute (NHLI) within the Faculty of Medicine at Imperial College London. His career bridges academia and industry, with expertise in respiratory inflammation, infection, and aging. He co-founded RespiVert Ltd., Pulmocide Ltd., and SubIntro Ltd., focusing on inhaled therapies for respiratory diseases.
Education:
- PhD, Hokkaido University (1995)
- Master of Veterinary Medicine, Hokkaido University (1987–1989)
Research Interests:
- Respiratory infections (bacteria, fungi, viruses)
- Cellular senescence and aging in COPD
- Inhaled drug development for antimicrobial resistance
- Epigenetic and signaling pathways in asthma/COPD
His work combines translational pharmacology with clinical biomarker studies, emphasizing novel therapies for corticosteroid-resistant inflammation.
Advancing Science:
- Secured £5.8M+ in Wellcome Trust/MRC grants
- Supervised 13 PhD students and 35+ international researchers
- Co-developed inhaled kinase inhibitors licensed to Janssen
Labs & Networks:
- Imperial College spin-off companies
- Member of Genomic and Environmental Medicine Section
- Affiliated with Fungal Science Network, Microbiome Network
0Publications listed
Find Kazuhiro Ito elsewhere
Related Searches
You Might Also Like
- CCoen WiegmanImperial College London · Lecturer
- MMichael EdwardsImperial College London · Senior Lecturer
Peter BarnesImperial College London · Professor
Simon LeaThe University of Manchester · Research Fellow- AAndrew HighamThe University of Manchester · Research Fellow
- PPankaj BhavsarImperial College London · Research Fellow